Literature DB >> 10987452

Quality of sexually transmitted disease treatments in the formal and informal sectors of Bangui, Central African Republic.

P Somsé1, F Mberyo-Yaah, P Morency, M J Dubois, G Grésenguet, J Pépin.   

Abstract

BACKGROUND: Interventions for upgrading sexually transmitted disease (STD) management in sub-Saharan Africa have focused on the public sector, and to a much lower extent on private medical practitioners and pharmacies. However, in most African cities there is a large informal sector that provides care to many patients with STD symptoms. GOAL: To compare the quality of treatments offered to patients with major STD syndromes in the public sector, pharmacies, and the informal sector of the same city. STUDY
DESIGN: Healthcare providers in health centers, pharmacies, private laboratories, and market drug peddlers in Bangui, Central African Republic, were asked to complete a short form for every patient consulting them with genital complaints. The treatments they ordered were evaluated for their potential efficacy against the major etiologic agents of the syndrome for which the patient consulted.
RESULTS: The majority of male patients with STDs preferred to seek care in pharmacies and in the informal sector. The STD treatments offered to patients with urethral discharge or genital ulcers in pharmacies and in the informal sector tended to focus on a single etiologic agent. The quality of STD treatments offered by drug peddlers and private laboratories was poor, apart from adequate coverage of syphilis in patients with genital ulcers and of candidiasis in women with vaginal discharge. For instance, 41% and 34% of patients with urethral discharge managed by drug peddlers and private laboratories did not receive a drug active against either Neisseria gonorrhoeae or Chlamydia trachomatis, whereas this proportion was 22% in pharmacies and 14% in health centers. For patients with genital ulcers, the proportion offered a drug active against Haemophilus ducreyi was 2% if seen by drug peddlers, 0% in laboratories, 10% in pharmacies, and 25% in health centers. For each syndrome and each category of provider, between one fourth and two thirds of patients had already received another ineffective treatment elsewhere.
CONCLUSION: National STD and HIV control programs will have to improve STD management in pharmacies and in the informal sector if they are to have any impact on the dynamics of HIV infection in urban centers.

Entities:  

Mesh:

Year:  2000        PMID: 10987452     DOI: 10.1097/00007435-200009000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

1.  Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants.

Authors:  A N Turner; C Ellertson; S Thomas; S García
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

2.  Aetiology of urethral discharge in Bangui, Central African Republic.

Authors:  P Morency; M J Dubois; G Grésenguet; E Frost; B Mâsse; S Deslandes; P Somsé; A Samory; F Mberyo-Yaah; J Pépin
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

3.  Cross-sectional survey of treatment practices for urethritis at pharmacies, private clinics and government health facilities in coastal Kenya: many missed opportunities for HIV prevention.

Authors:  Peter M Mugo; Sarah Duncan; Samuel W Mwaniki; Alexander N Thiong'o; Evanson Gichuru; Haile Selassie Okuku; Elise M van der Elst; Adrian D Smith; Susan M Graham; Eduard J Sanders
Journal:  Sex Transm Infect       Date:  2013-05-22       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.